Enzymatic Therapy and Twinlab to market the dietary supplement following the expiration of GNC's initially exclusive distribution rights; the retailer will continue to market the product ("The Tan Sheet" Feb. 2, p. 13). Green Bay, Wisc.-based Enzymatic Therapy plans to introduce a 60-count 7-Keto in 25 mg capsules at health food stores beginning June 30; ET will discontinue its other DHEA products. Humanetics is advertising the brand in consumer health magazines including Natural Health, Let's Live, Delicious and Vegetarian Times; ET has no plans for additional advertising, although it will promote the product at the NNFA Marketplace in July. Hauppauge, N.Y.-based Twinlab will introduce 7-Keto in late August...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.
Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.
The new Advisory Committee on Immunization Practices voted for new recommendations on the decades-old thimerosal safety issue and lays intellectual groundwork to revisit other past controversies and decisions.
